Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Cardiac condition during cooling and rewarming periods of therapeutic hypothermia after cardiopulmonary resuscitation

BMC Anesthesiology volume 14, Article number: 78 (2014) Cite this article

Abstract

Background

Hypothermia has been used in cardiac surgery for many years for neuroprotection. Mild hypothermia (MH) [body temperature (BT) kept at 32–35°C] has been shown to reduce both mortality and poor neurological outcome in patients after cardiopulmonary resuscitation (CPR). This study investigated whether patients who were expected to benefit neurologically from therapeutic hypothermia (TH) also had improved cardiac function.

Methods

The study included 30 patients who developed in-hospital cardiac arrest between September 17, 2012, and September 20, 2013, and had return of spontaneous circulation (ROSC) following successful CPR. Patient BTs were cooled to 33°C using intravascular heat change. Basal BT, systolic artery pressure (SAP), diastolic artery pressure (DAP), mean arterial pressure (MAP), heart rate, central venous pressure, cardiac output (CO), cardiac index (CI), global end-diastolic volume index (GEDI), extravascular lung water index (ELWI), and systemic vascular resistance index (SVRI) were measured at 36°C, 35°C, 34°C and 33°C during cooling. BT was held at 33°C for 24 hours prior to rewarming. Rewarming was conducted 0.25°C/h. During rewarming, measurements were repeated at 33°C, 34°C, 35°C and 36°C. A final measurement was performed once patients spontaneously returned to basal BT. We compared cooling and rewarming cardiac measurements at the same BTs.

Results

SAP values during rewarming (34°C, 35°C and 36°C) were lower than during cooling (P < 0.05). DAP values during rewarming (basal temperature, 34°C, 35°C and 36°C) were lower than during cooling. MAP values during rewarming (34°C, 35°C and 36°C) were lower than during cooling (P < 0.05). CO and CI values were higher during rewarming than during cooling. GEDI and ELWI did not differ during cooling and rewarming. SVRI values during rewarming (34°C, 35°C, 36°C and basal temperature) were lower than during cooling (P < 0.05).

Conclusions

To our knowledge, this is the first study comparing cardiac function at the same BTs during cooling and rewarming. In patients experiencing ROSC following CPR, TH may improve cardiac function and promote favorable neurological outcomes.

Peer Review reports

Background

Hypothermia has been used in cardiac surgery for many years for neuroprotection [1, 2]. Mild hypothermia (body temperature (BT) maintained at 32–35°C) has been shown to reduce mortality and improve neurological status by 24–30% in patients who have undergone cardiopulmonary resuscitation (CPR) [3]. Although severe hypothermia (BT <31°C) damages cardiac function, mild hypothermia produces a cardioprotective effect [4, 5].

Post-cardiac arrest brain injury results from global brain ischemia during the reduction in general blood flow [6], and prolonged cardiovascular collapse negatively impacts neurologic outcome [7]. Therapeutic hypothermia (TH) is the process whereby BT is reduced to a target temperature of 32–34°C and maintained at this temperature for 24–48 hours following cardiac arrest (CA) and return of spontaneous circulation (ROSC) [8–11]. The 2010 International Consensus on CPR and Emergency Cardiovascular Care Science treatment recommendations [12], the 2010 American Heart Association CPR guidelines [13], the 2010 Japan Resuscitation Council Guidelines [14], and the 2010 European Resuscitation Council (ERC) Guidelines [15] recommend TH following ROSC regardless of cardiac rhythm.

The aim of this study was to determine whether patients who were likely to benefit neurologically from TH would also experience favorable effects on cardiac function. Thus, we measured cardiac function during cooling and rewarming periods in patients receiving TH after CPR.

Methods

Patients were eligible if they developed CA in our hospital and acquired ROSC following successful CPR between September 17, 2012, and September 20, 2013 (Figure 1).

Figure 1
figure 1

Flow diagram of the study.

Full size image

Patients were excluded if they: developed CA outside the hospital; were < 15 years old; had late stage cancer; demonstrated severe cardiogenic shock; were pregnant; had cerebrovascular disease; demonstrated severe heart disease or pulmonary artery thromboembolism; or had aortic dissection or aneurysm.

Participants were admitted to the intensive care unit and received care consistent with 2010 ERC guidelines [15]. For internal BT measurements, a 16 F caliber, 44 cm heat probe silicone urinary catheter (Rusch® sensor series 400, Teleflex Medical IDA Business and Technology Park, Athlone, Ireland) was inserted. A 7 F three lumen central venous catheter (GE-CVC3720Y, GEMED®, Istanbul, Turkey) was placed in the right subclavian vein. A 9.3 F caliber, five-lumen intravascular heat change catheter (IC-3893 AE, ICY Intravascular Heat Exchange Catheter Kit®, ZOLL Circulation Inc., Sunnyvale, CA, USA) was placed into the right femoral vein. A 4 F caliber, 16 cm Philips Continuous Cardiac Output arterial thermodilution catheter (PiCCO Plus®, Pulsion Medical Systems AG, Munich, Germany) was placed in the right femoral artery and connected to the monitor.

Patients were sedated with midazolam 0.02 mg/kg/h and remifentanil 60 μg/kg/h intravenous infusions according to the Ramsay Sedation Scale level 3–4 [16]. Sedation was continued throughout TH and rewarming. During cooling, patients who demonstrated shaking that could adversely affect hemodynamic balance received 0.03–0.05 mg/kg vecuronium intravenously. Consistent with hospital protocol, patients whose mean arterial pressure (MAP) was less than 60 mmHg and unresponsive to a volume challenge received intravenous dopamine and noradrenalin infusion.

Patient BTs were cooled to 33°C using intravascular heat change at a rate of 0.5°C/h (Thermogard XP®, Alsius Corp., Chelmsford, MA, USA). Basal BT, systolic artery pressure (SAP), diastolic artery pressure (DAP), MAP, heart rate (HR), central venous pressure (CVP), cardiac output (CO), cardiac index (CI), global end-diastolic volume index (GEDI), extravascular lung water index (ELWI) and systemic vascular resistance index (SVRI) values were measured at 36°C, 35°C, 34°C and 33°C during cooling. During the measurements, 15 mL of 0.9% saline solution at a temperature of less than 8°C was administered through a central venous catheter over 10 seconds or less. Measurements were obtained with the help of thermodilution curves using the PiCCO® plus device. To ensure reliability, three injections and three series of measurements were performed for each temperature point, and mean values were used for analysis. Incompatible values among injections were deleted and the measurements were repeated. Central catheters were recessed during measurements. BT was held at 33°C for 24 hours prior to rewarming. Rewarming was conducted at 0.25°C/h. During rewarming, measurements were repeated at 33°C, 34°C, 35°C and 36°C. A final measurement was performed when patients spontaneously returned to basal BT.

We compared cooling and rewarming cardiac measurements conducted at the same BTs using means, standard deviations, ranges, medians, ratios and frequencies. Variable distribution was controlled using the Kolmogorov Smirnov test. Repeated measurements were analyzed with paired sample t-tests. SPSS 21.0 software (IBM® Corp., Armonk, NY, USA) was used to analyze the data.

Permission to conduct this study was obtained from the Clinical Studies Local Ethics Committee of the Republic of Turkey Ministry of Health, Bagcilar Training and Research Hospital (17.09.2012-76). Written informed consent was obtained from the patients’ first degree relatives.

Results

Patient demographic characteristics are presented in Table 1. Cardiac measurements during cooling and rewarming are shown in Table 2. SAP measurements during rewarming at 34°C and 35°C were lower than during rewarming at 33°C (P < 0.05). DAP values did not differ during cooling or rewarming. MAP values during rewarming at 34°C, 35°C and 36°C were lower than at 33°C (P < 0.05). HR values during cooling at 35°C, 34°C and 33°C were lower than at basal temperature (P < 0.05). HR values during rewarming at 34°C, 35°C, 36°C and basal temperature were higher than at 33°C (P < 0.05). CVP values during rewarming at 35°C and 36°C were lower than at 33°C (P < 0.05). CO values during cooling at 35°C and 33°C were lower than at basal temperature (P < 0.05). CO values during rewarming to basal temperature were higher than at 33°C (P < 0.05). CI values during cooling at 36°C, 35°C and 33°C were lower than at basal temperature (P < 0.05). CI values during rewarming to basal temperature were higher than at 33°C (P < 0.05). GEDI values during cooling at 36°C were lower than at basal temperature. GEDI values at 33°C were higher than at basal temperature (P < 0.05). GEDI values during rewarming at 35°C and basal temperature were higher than at 33°C (P < 0.05). ELWI values during cooling at 36°C and 35°C were higher than at basal temperature (P < 0.05). SVRI values during cooling at 35°C and 34°C were higher than at basal temperature (P < 0.05). SVRI values during rewarming at 34°C, 35°C, 36°C and at basal temperature were higher than at 33°C (P < 0.05).

Table 1 Summary of demographic and clinical characteristics of the 30 patients with cardiac arrest
Full size table
Table 2 Variation for the cardiac thermodilution maesurements at the same body temperature during cooling and rewarming periods
Full size table

Some cardiac function values differed when measured at the same temperature during cooling and rewarming phases. SAP values at 34°C, 35°C and 36°C were lower during rewarming compared with cooling (P < 0.05). DAP values at basal temperature, 34°C, 35°C and 36°C were lower during rewarming than during cooling. MAP values at 34°C, 35°C and 36°C were lower during rewarming than during cooling (P < 0.05). HR, CVP, GEDI and ELWI values at the same BT did not differ between cooling and rewarming periods. CO values were higher during rewarming than during cooling (P < 0.05). CI values were higher during rewarming than during cooling (P < 0.05). SVRI values at 34°C, 35°C, 36°C and basal temperature were lower during rewarming than during cooling (P < 0.05) (Table 2).

Discussion

In our comparison of cardiac function during the cooling and rewarming following CA and ROSC, we found that the greatest improvement occurred at 33°C at the beginning of the rewarming period and that improvement in cardiac function continued throughout the rewarming period. This was consistent with a recent study showing that patients kept at 33°C BT for about 24 hours experienced improved cardiac function during rewarming.

The rationale for applying TH in patients experiencing ROSC after CPR is to improve brain tolerance to ischemia. There are increasing reports of neurological disease-free survival and recovery in these situations [17, 18]. Experimental studies demonstrated that hypothermic blood introduced to the coronary sinus during heart ischemia minimizes reperfusion damage and infarct area [19]. TH also protects contractility, prevents microvascular obstructions, and reduces left ventricular remodeling [20]. In addition, the reduced metabolic rate, decreased tissue apoptosis, and heat shock protein induction offer cellular protective effects [21]. The cardioprotective effects of TH are directly related to timing. Late induction or a slow cooling speed does not improve cardiac function [22, 23]. The time from ROSC to TH induction was about 45 minutes in our study. Although we selected 0.5°C/h for cooling, new studies suggest that faster cooling (>0.5°C/h) to the targeted BT is associated with better cardioprotection [24, 25]. According to Nagao et al., TH is more effective if begun during CPR prior to ROSC, and early cooling during CA is neuroprotective and myocardioprotective [26]. TH during CPR also increases resuscitation rates, improves cardiac and left ventricular function and decreases the myocardial infarct area [27, 28].

Schmidt-Schweda et al. showed that HR decreased whereas stroke volume (SV), CI and CO increased in cardiomyopathic patients receiving short-term cooling [29]. However, these improvements were lost during rewarming, and the authors interpreted TH application as having a positive inotropic effect [29]. In contrast, CO and CI in our study improved at the end of the cooling period and throughout rewarming, with the highest levels occurring at the end of the process. As per our protocol, dopamine and noradrenalin infusions were decreased or eliminated during rewarming. There were significant increases in CO and CI, and a significant decrease in SVRI, but no significant change in GEDI or HR during the rewarming period compared with the cooling period. This might imply that there was an increased SV during the rewarming period resulting from either increased contractility or decreased afterload or both. Unfortunately, recent study findings could not distinguished between the two possibilities. Gibson et al. suggested that the TH adverse effects of bradycardia and hypotension actually benefit patients, similar to the effect of beta-blockers [30]. When Riaz et al. reported results of cooling patients to 32°C to 34°C for 24 hours following ventricular tachycardia or ventricular fibrillation, they emphasized the risk of QT interval prolongation, particularly in those who had received amiodarone [31].

Management of patients receiving CPR during TH is difficult [8, 9]. The most frequent cause of complex hemodynamic instability is arterial hypotension, which is characterized by hypovolemia, reversible myocardial stunning and excessive vasodilation [32–36]. Pulmonary dysfunction is related to cardiogenic pulmonary edema caused by left ventricular dysfunction and non-cardiogenic edema caused by inflammatory, infective and physical damage [9]. We used PiCCO® monitoring to improve patient care and track cardiac function during this difficult post-ROSC period. It has been reported that PiCCO® monitoring with transpulmonary thermodilution may be compromised in patients receiving TH [37, 38]. For this reason, we compared cardiac function measurements at the same BTs during cooling and rewarming. However, there are inadequate prospective studies published regarding the reliability of PiCCO® measurements at low BTs. Further prospective studies similar to ours are needed. Fluid and electrolyte balance during TH is an important challenge [39]. Cooling can cause peripheral vasoconstriction, reduce vascular volume and CVP, and the patient seems relatively hypovolemic [40]. In our study, we detected no significant change in CVP and HR, but we did detect higher CO and CI values. During these therapeutic cooling and rewarming periods, patient fluid status must be monitored closely to maintain volume balance, and a vasopressor added when necessary to maintain adequate blood pressure.

Post-resuscitation hemodynamic instability is characterized by a low CI and normal or low filling pressures [33]. The CI rapidly increases 24 hour after CA, independent of filling pressures and vasoactive agents [41]. Recovery of this myocardial dysfunction is most often obtained within 24–48 hours and this condition might have played a role in our findings [33]. Full recovery with discontinuation of inotropic support has usually occurred by 72 hours after ROSC [41]. In contrast, TH has been shown to produce negative effects as well as cardioprotective effects. Espinoza et al. showed that TH in pigs decreased SV, ejection fraction and strain in hearts paced at 33°C, and concluded that TH may lead to systolic and diastolic dysfunction [42]. When Bassin et al. induced hypothermia in sheep using venous extracorporeal circulation, they observed increased heterogeneity in hypothermic depolarization and repolarization during cardiac rhythm tracking by 12-derivation ECG, thus providing strong evidence that hypothermia to 34°C produced adverse effects [43].

Several limitations of the current study deserve mention. We did not select a control group so we do not know how cardiac functions would have differed from patients who did not receive TH. We were also unable to study patients undergoing angioplasty following CA as a result of myocardial infarction or patients with known underlying cardiac disease. Once TH was complete, we did not collect PiCCO® measurements. Thus, we could not determine whether the beneficial cardiac function changes persisted over time.

Conclusions

This study found that CO and CI increased together during rewarming following TH. The lack of difference in HR measurements indicate that CO and CI increased by increases in TH and SV. To our knowledge, this is the first study comparing cardiac function at the same BTs during cooling and rewarming. In patients experiencing ROSC following CPR, TH may improve cardiac function. Further studies are needed to confirm these results and the relationship between TH and post-resuscitation myocardial function in patients with different neurological status.

Abbreviations

MH:

Mild hypothermia

BT:

Body temperature

CPR:

Cardiopulmonary resuscitation

TH:

Therapeutic hypothermia

ROSC:

Return of spontaneous circulation

SAP:

Systolic artery pressure

DAP:

Diastolic artery pressure

MAP:

Mean arterial pressure

CO:

Cardiac output

CI:

Cardiac index

GEDI:

Global end-diastolic volume index

ELWI:

Extravascular lung water index

SVRI:

Systemic vascular resistance index

CA:

Cardiac arrest

ERC:

European Resuscitation Council

HR:

Heart rate

CVP:

Central venous pressure

SV:

Stroke volume.

References

  1. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002, 346: 557-569. 10.1056/NEJMoa003289.

    Article  PubMed  Google Scholar 

  2. The Hypothermia after Cardiac Arrest Study Group: Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002, 346: 549-556.

    Article  Google Scholar 

  3. Gardner G, MacDonald S: Caring for patients receiving therapeutic hypothermia post cardiac arrest in the intensive care unit. Can J Cardiovasc Nurs. 2013, 23: 15-17.

    PubMed  Google Scholar 

  4. Chien GL, Wolff RA, van Winkle DM: Normothermic range temperature affects myocardial infarct size. Cardiovasc Res. 1994, 28: 1014-1017. 10.1093/cvr/28.7.1014.

    Article  CAS  PubMed  Google Scholar 

  5. Tissier R, Chenoune M, Ghaleh B, Cohen MV, Downey JM, Berdeaux A: The small chill: mild hypothermia for cardioprotection. Cardiovasc Res. 2010, 88: 406-414. 10.1093/cvr/cvq227.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Negovsky VA: Postresuscitation disease. Crit Care Med. 1988, 16: 942-946. 10.1097/00003246-198810000-00004.

    Article  CAS  PubMed  Google Scholar 

  7. Morrison LJ, Deakin CD, Morley PT, Callaway CW, Kerber RE, Kronick SL, Lavonas EJ, Link MS, Neumar RW, Otto CW, Parr M, Shuster M, Sunde K, Peberdy MA, Tang W, Hoek TL, Böttiger BW, Drajer S, Lim SH, Nolan JP, Advanced Life Support Chapter Collaborators: International consensus on cardiopulmonary resusitation and emergency cardiovascular care science with treatment recommendations. Circulation. 2010, 122: 345-421. 10.1161/CIRCULATIONAHA.110.971051.

    Article  Google Scholar 

  8. Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, Böttiger BW, Callaway C, Clark RS, Geocadin RG, Jauch EC, Kern KB, Laurent I, Longstreth WT, Merchant RM, Morley P, Morrison LJ, Nadkarni V, Peberdy MA, Rivers EP, Rodriguez-Nunez A, Sellke FW, Spaulding C, Sunde K, Vanden HT: Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication: a consensus statement from the international Liaison Committee. Circulation. 2008, 118: 2452-2483. 10.1161/CIRCULATIONAHA.108.190652.

    Article  PubMed  Google Scholar 

  9. Peberdy MA, Callaway CW, Neumar RW, Geocadin RG, Zimmerman JL, Donnino M, Gabrielli A, Silvers SM, Zaritsky AL, Merchant R, Vanden Hoek TL, Kronick SL: American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010, 122: 768-786. 10.1161/CIRCULATIONAHA.110.971002.

    Article  Google Scholar 

  10. Binks AC, Murphy RE, Prout RE, Bhayani S, Griffiths CA, Mitchell T, Padkin A, Nolan JP: Therapeutic hypothermia after cardiac arrest implementation in UK intensive care units. Anaesthesia. 2010, 65: 260-265. 10.1111/j.1365-2044.2009.06227.x.

    Article  CAS  PubMed  Google Scholar 

  11. Laver SR, Padkin A, Atalla A, Nolan JP: Therapeutic hypothermia after cardiac arrest: a survey of practice in intensive care units in the United Kingdom. Anaesthesia. 2006, 61: 873-877. 10.1111/j.1365-2044.2006.04552.x.

    Article  CAS  PubMed  Google Scholar 

  12. Hazinski MF, Nolan JP, Billi JE, Böttiger BW, Bossaert L, de Caen AR, Deakin CD, Drajer S, Eigel B, Hickey RW, Jacobs I, Kleinman ME, Kloeck W, Koster RW, Lim SH, Mancini ME, Montgomery WH, Morley PT, Morrison LJ, Nadkarni VM, O'Connor RE, Okada K, Perlman JM, Sayre MR, Shuster M, Soar J, Sunde K, Travers AH, Wyllie J, Zideman D: International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Circulation. 2010, 122: 250-275. 10.1161/CIRCULATIONAHA.110.970897.

    Article  Google Scholar 

  13. Field JM, Hazinski MF, Sayre MR, Chameides L, Schexnayder SM, Hemphill R, Samson RA, Kattwinkel J, Berg RA, Bhanji F, Cave DM, Jauch EC, Kudenchuk PJ, Neumar RW, Peberdy MA, Perlman JM, Sinz E, Travers AH, Berg MD, Billi JE, Eigel B, Hickey RW, Kleinman ME, Link MS, Morrison LJ, O'Connor RE, Shuster M, Callaway CW, Cucchiara B, Ferguson JD, et al: American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010, 122: 640-656.

    Article  Google Scholar 

  14. Hori S: New evidences in the 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care with treatment recommendations. Nihon Rinsho. 2011, 69 (4): 605-611.

    PubMed  Google Scholar 

  15. Nolan JP, Soar J, Zideman DA, Biarent D, Bossaert LL, Deakin C, Koster RW, Wyllie J, Böttiger B: European Resuscitation Council Guidelines for Resuscitation 2010. Resuscitation. 2010, 81: 1219-1276. 10.1016/j.resuscitation.2010.08.021.

    Article  PubMed  Google Scholar 

  16. Ramsay MA, Savage TM, Simpson BR, Goodwin R: Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974, 2: 656-659. 10.1136/bmj.2.5920.656.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Hay AW, Swann DG, Bell K, Walsh TS, Cook B: Therapeutic hypothermia in comatose patients after out-of hospital cardiac arrest. Anaesthesia. 2008, 34: 1865-1873.

    Google Scholar 

  18. Nielsen N, Hovdenes J, Nilsson F, Rubertsson S, Stammet P, Sunde K, Valsson F, Wanscher M, Friberg H: Outcome, timing and advers events in therapeutic hypothermia after-out-of-hospital cardiac arrest. Acta Anaesthesiol Scand. 2009, 53: 926-934. 10.1111/j.1399-6576.2009.02021.x.

    Article  CAS  PubMed  Google Scholar 

  19. Haendchen RV, Corday E, Meerbaum S, Povzhitkov M, Rit J, Fishbein MC: Prevention of ischemic injury and early reperfusion derangements by hypothermic retroperfusion. Am Coll Cardiol. 1983, 1: 1067-1080. 10.1016/S0735-1097(83)80109-0.

    Article  CAS  Google Scholar 

  20. Hale SL, Kloner RA: Mild hypothermia as a cardioprotective approach for acute myocardial infarction: laboratory to clinical application. J Cardiovasc Pharmacol Ther. 2011, 16: 131-139. 10.1177/1074248410387280.

    Article  PubMed  Google Scholar 

  21. Ma H, Sinha B, Pandya RS, Lin N, Popp AJ, Li J, Yao J, Wang X: Therapeutic hypothermia as a neuroprotective strategy in neonatal hypoxic-ischemic brain injury and traumatic brain injury. Curr Mol Med. 2012, 12: 1282-1296. 10.2174/156652412803833517.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Deakin CD, Nolan JP, Soar J, Sunde K, Koster RW, Smith GB, Perkins GD: European Resuscitation Council Guidelines for Resuscitation 2010: Adult advanced life support. Resuscitation. 2010, 81: 1305-1352. 10.1016/j.resuscitation.2010.08.017.

    Article  PubMed  Google Scholar 

  23. van der Wal G, Brinkman S, Bisschops LL, Hoedemaekers CW, van der Hoeven JG, de Lange DW, de Keizer NF, Pickkers P: Influence of mild therapeutic hypothermia after cardiac arrest on hospital mortality. Crit Care Med. 2011, 39: 84-88. 10.1097/CCM.0b013e3181fd6aef.

    Article  PubMed  Google Scholar 

  24. Sunde K, Pytte M, Jacobsen D, Mangschau A, Jensen LP, Smedsrud C, Draegni T, Steen PA: Implementation of a standardised treatment protocol for post resuscitation care after out-of-hospital cardiac arrest. Resuscitation. 2007, 73: 29-39. 10.1016/j.resuscitation.2006.08.016.

    Article  PubMed  Google Scholar 

  25. Nunnally ME, Jaeschke R, Bellingan GJ, Lacroix J, Mourvillier B, Rodriguez-Vega GM, Rubertsson S, Vassilakopoulos T, Weinert C, Zanotti-Cavazzoni S, Buchman TG: Targeted temperature management in critical care: a report and recommendations from five five professional societies. Crit Care Med. 2011, 16: 1113-1125.

    Article  Google Scholar 

  26. Nagao K: Therapeutic hypothermia following resuscitation. Curr Opin Crit Care. 2012, 18 (3): 239-245. 10.1097/MCC.0b013e3283523f4a.

    Article  PubMed  Google Scholar 

  27. Abella BS, Zhao D, Alvarado J, Hamann K, Vanden Hoek TL, Becker LB: Intra-arrest cooling improves outcomes in a murine cardiac arrest model. Circulation. 2004, 16: 2786-2791.

    Article  Google Scholar 

  28. Scolletta S, Taccone FS, Nordberg P, Donadello K, Vincent JL, Castren M: Intra-arrest hypothermia during cardiac arrest: a systematic review. Crit Care. 2012, 16 (2): R41-10.1186/cc11235.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Schmidt-Schweda S, Ohler A, Post H, Pieske B: Moderate hypothermia for severe cardiogenic shock. Resuscitation. 2013, 84: 319-325. 10.1016/j.resuscitation.2012.09.034.

    Article  PubMed  Google Scholar 

  30. Gibson A, Andrews PJ: Therapeutic hypothermia, still "too cool to be true?". F1000Prime Rep. 2013, 5: 26-

    Article  PubMed  PubMed Central  Google Scholar 

  31. Riaz A, Hieb H, Foley B, Mulvihill N, Crean P, Murphy RT, Daly C, Boyle N: Safety of therapeutic hypothermia in post VF/VT cardiac arrest patients. Ir Med J. 2013, 106 (2): 55-56.

    CAS  PubMed  Google Scholar 

  32. Kelly FE, Nolan JP: The effect of mild induced hypothermia on the myocardium: a systematic review. Anaesthesia. 2010, 65: 505-515. 10.1111/j.1365-2044.2009.06237.x.

    Article  PubMed  Google Scholar 

  33. Laurent I, Monchi M, Chiche JD, Joly LM, Spaulding C, Bourgeois B, Cariou A, Rozenberg A, Carli P, Weber S, Dhainaut JF: Reversibl myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol. 2002, 40: 2110-2116. 10.1016/S0735-1097(02)02594-9.

    Article  PubMed  Google Scholar 

  34. Chang WT, Ma MH, Chien KL, Huang CH, Tsai MS, Shih FY, Yuan A, Tsai KC, Lin FY, Lee YT, Chen WJ: Postresuscitation myocardial dsyfunction: correlated factors and prognostic implications. Intensive Care Med. 2007, 33: 88-95. 10.1007/s00134-006-0442-9.

    Article  PubMed  Google Scholar 

  35. Adrie C, Adib-Conquy M, Laurent I, Monchi M, Vinsonneau C, Fitting C, Fraisse F, Dinh-Xuan AT, Carli P, Spaulding C, Dhainaut JF, Cavaillon JM: Successful cardiopulmonary resuscitation after cardiac arrest as a sepsis like syndrome. Circulation. 2002, 106: 562-568. 10.1161/01.CIR.0000023891.80661.AD.

    Article  PubMed  Google Scholar 

  36. Adrie C, Laurent I, Monchi M, Cariou A, Dhainaou JF, Spaulding C: Postresuscitation disease after cardiac arrest: sepsis like syndrome?. Curr Opin Crit Care. 2004, 10: 208-212. 10.1097/01.ccx.0000126090.06275.fe.

    Article  PubMed  Google Scholar 

  37. Monnet X, Persichini R, Ktari M, Jozwiak M, Richard C, Teboul JL: Precision of the transpulmonary thermodilution measurements. Crit Care. 2011, 15: 204-

    Article  Google Scholar 

  38. Gondos T, Marjanek Z, Kisvarga Z, Halasz G: Precision of transpulmonary thermodilution: how many measurements are necessary?. Eur J Anaesthesiol. 2009, 26: 508-512. 10.1097/EJA.0b013e32832a2d23.

    Article  PubMed  Google Scholar 

  39. Prempunpong C, Efanov I, Santanna G: The effect of implementation of therapeutic hypothermia on fluid balance and incidence of hyponatremia in neonates with moderate or severe hypoxic-ischaemic encephalopathy. Acta Paediatr. 2013, 102 (11): e507-e513.

    PubMed  Google Scholar 

  40. Davies MG, Hopkin MA, Brockbank KG, Hagen PO: Hypothermia and rewarming after hypothermic exposure alter venous relaxation. Vasc Med. 1996, 1: 103-107.

    CAS  PubMed  Google Scholar 

  41. Kern KB, Hilwig RW, Rhee KH, Berg RA: Myocardial dysfunction of resuscitation from cardiac arrest: an example of global myocardial stunning. J Am Coll Cardiol. 1996, 28: 232-240. 10.1016/0735-1097(96)00130-1.

    Article  CAS  PubMed  Google Scholar 

  42. Espinoza A, Kerans V, Opdahl A, Skulstad H, Halvorsen PS, Bugge JF, Fosse E, Edvardsen T: Effects of therapeutic hypothermia on left ventricular function assessed by ultrasound imaging. J Am Soc Echocardiogr. 2013, 26 (11): 1353-1363. 10.1016/j.echo.2013.06.021.

    Article  PubMed  Google Scholar 

  43. Bassin L, Yong AC, Kilpatrick D, Hunyor SN: Arrhythmogenicity of hypothermia- a large animal model of hypothermia. Heart Lung Circ. 2014, 23 (1): 82-87. 10.1016/j.hlc.2013.07.001.

    Article  PubMed  Google Scholar 

Pre-publication history

Download references

Acknowledgements

We thank to Jack Tuncay (Istanbul, Turkey) and Squirrel Scribe, LLC (NewYork, USA) for professional language editing.

Author information

Authors and Affiliations

  1. Department of Anesthesiology and Reanimation, Bagcilar Educational and Training Hospital, Şenlikköy Mah, İncir Sokak, No:1/3, Sarı Konaklar Sitesi, B-Blok, Daire:6, Florya/ Bakırköy, Istanbul, Turkey

    Serdar Demirgan, Kerem Erkalp, M Salih Sevdi, Meltem Turkay Aydogmus, Numan Kutbay, Aydin Firincioglu, Ali Ozalp & Aysin Alagol

Authors
  1. Serdar Demirgan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kerem Erkalp
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Salih Sevdi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Meltem Turkay Aydogmus
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Numan Kutbay
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Aydin Firincioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ali Ozalp
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Aysin Alagol
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kerem Erkalp.

Additional information

Competing interests

The authors declare they have no competing interests.

Authors’ contributions

SD conceived and designed the study, conducted the literature review, wrote and critically reviewed the paper. KE conceived and designed the study, analyzed and interpreted the data, conducted the literature review, wrote and critically reviewed the paper. MSS supervised the study, conducted the literature review, wrote and critically reviewed the paper. MTA supervised the study, analyzed and interpreted the data. AA supervised the study, analyzed and interpreted the data, and critically reviewed the paper. NK provided funding and materials, and collected and processed the data. AF provided funding and materials, and collected and processed the data. AO provided funding and materials. All authors read and approved the final manuscript.

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.

Authors’ original file for figure 1

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Demirgan, S., Erkalp, K., Sevdi, M.S. et al. Cardiac condition during cooling and rewarming periods of therapeutic hypothermia after cardiopulmonary resuscitation. BMC Anesthesiol 14, 78 (2014). https://doi.org/10.1186/1471-2253-14-78

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/1471-2253-14-78

Keywords

BMC Anesthesiology

ISSN: 1471-2253

Contact us